The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-benzyl-3-[4-(3-chlorophenyl)piperazin-1-yl]-N-[2-(dimethylamino)ethyl]benzene-1-sulfonamide ID: ALA3754784
PubChem CID: 127026349
Max Phase: Preclinical
Molecular Formula: C27H33ClN4O2S
Molecular Weight: 513.11
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)CCN(Cc1ccccc1)S(=O)(=O)c1cccc(N2CCN(c3cccc(Cl)c3)CC2)c1
Standard InChI: InChI=1S/C27H33ClN4O2S/c1-29(2)14-19-32(22-23-8-4-3-5-9-23)35(33,34)27-13-7-12-26(21-27)31-17-15-30(16-18-31)25-11-6-10-24(28)20-25/h3-13,20-21H,14-19,22H2,1-2H3
Standard InChI Key: CBWBSLUIEODKRP-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5987 1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6012 3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9015 3.7484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1993 2.9963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1969 1.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8967 0.7484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2352 0.8946 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.5359 -1.3582 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4978 -0.7562 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.5383 -0.1583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2094 3.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9126 3.7566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2044 1.5002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5012 0.7446 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8021 1.4930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9166 4.9566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8712 3.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8055 2.9938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1046 3.7436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1049 5.2436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8060 5.9939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5068 5.2441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5065 3.7441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1969 -1.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8991 -0.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5987 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5965 -3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8943 -3.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1945 -3.0045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
4 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
11 13 1 0
15 14 2 0
16 15 2 0
17 18 1 0
17 19 1 0
19 20 1 0
20 21 1 0
18 22 1 0
18 23 1 0
21 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
20 15 1 0
15 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
32 1 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 513.11Molecular Weight (Monoisotopic): 512.2013AlogP: 4.42#Rotatable Bonds: 9Polar Surface Area: 47.10Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 7.54CX LogP: 5.22CX LogD: 4.84Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.42Np Likeness Score: -1.65
References 1. Éliás O, Nógrádi K, Domány G, Szakács Z, Kóti J, Szántay C, Tarcsay Á, Keserű GM, Gere A, Kiss B, Kurkó D, Kolok S, Némethy Z, Kapui Z, Hellinger É, Vastag M, Sághy K, Kedves R, Gyertyán I.. (2016) The influence of 5-HT(2A) activity on a 5-HT(2C) specific in vivo assay used for early identification of multiple acting SERT and 5-HT(2C) receptor ligands., 26 (3): [PMID:26748694 ] [10.1016/j.bmcl.2015.12.071 ]